17 – Placental Function in Intrauterine Growth Restriction
暂无分享,去创建一个
[1] L. Kauvar,et al. Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. , 2014, The Journal of infectious diseases.
[2] Jai K. Das,et al. Impact of intrauterine growth restriction on long-term health , 2014, Current opinion in clinical nutrition and metabolic care.
[3] D. Peebles,et al. Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies. , 2014, Human gene therapy.
[4] James M. Roberts,et al. Pathophysiology of ischemic placental disease. , 2014, Seminars in perinatology.
[5] B. Huppertz,et al. Trophoblast invasion and oxygenation of the placenta: measurements versus presumptions. , 2014, Journal of reproductive immunology.
[6] Guoyao Wu,et al. Down‐regulation of placental mTOR, insulin/IGF‐I signaling, and nutrient transporters in response to maternal nutrient restriction in the baboon , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] K. Thornburg,et al. Placental programming of chronic diseases, cancer and lifespan: a review. , 2013, Placenta.
[8] L. Moore,et al. Graduated effects of high-altitude hypoxia and highland ancestry on birth size , 2013, Pediatric Research.
[9] K. Thornburg,et al. The Obstetric Origins of Health for a Lifetime , 2013, Clinical obstetrics and gynecology.
[10] J. Kingdom,et al. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. , 2013, The Cochrane database of systematic reviews.
[11] A. Ferguson-Smith,et al. An obesogenic diet during mouse pregnancy modifies maternal nutrient partitioning and the fetal growth trajectory , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] B. Kalionis,et al. Homeobox genes and down-stream transcription factor PPARγ in normal and pathological human placental development. , 2013, Placenta.
[13] K. Yoshiura,et al. Characterization of placenta‐specific microRNAs in fetal growth restriction pregnancy , 2013, Prenatal diagnosis.
[14] T. Powell,et al. Review: Adiponectin--the missing link between maternal adiposity, placental transport and fetal growth? , 2013, Placenta.
[15] K. Joseph,et al. Fetal growth: a review of terms, concepts and issues relevant to obstetrics , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[16] Y. Kanai,et al. Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells , 2013, The Journal of physiology.
[17] M. Stronati,et al. Short-term and long-term sequelae in intrauterine growth retardation (IUGR) , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[18] D. Nicolella,et al. Baboons as a model to study genetics and epigenetics of human disease. , 2013, ILAR journal.
[19] T. Powell,et al. Regulation of Nutrient Transport across the Placenta , 2012, Journal of pregnancy.
[20] Gynecologists. Practice Bulletin No. 132: Antiphospholipid syndrome. , 2012, Obstetrics and gynecology.
[21] D. Goberdhan,et al. The emerging role of mTORC1 signaling in placental nutrient-sensing. , 2012, Placenta.
[22] A. Dessì,et al. Physiopathology of intrauterine growth retardation: from classic data to metabolomics , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[23] J. Kuller,et al. Antenatal Surveillance of Fetal Growth Restriction , 2012, Obstetrical & gynecological survey.
[24] T. Powell,et al. Placental transport in response to altered maternal nutrition , 2012, Journal of Developmental Origins of Health and Disease.
[25] M. Glocker,et al. A proteome signature for intrauterine growth restriction derived from multifactorial analysis of mass spectrometry‐based cord blood serum profiling , 2012, Electrophoresis.
[26] Lorie M. Harper,et al. Fetal congenital heart disease and intrauterine growth restriction: a retrospective cohort study , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[27] G. Burton,et al. Review: The placenta and developmental programming: balancing fetal nutrient demands with maternal resource allocation. , 2012, Placenta.
[28] Mathew B. Cox,et al. Evidence of endoplasmic reticulum stress and protein synthesis inhibition in the placenta of non-native women at high altitude , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] S. Ferrara,et al. Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation , 2011, Electrophoresis.
[30] S. Apostolidou,et al. Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restriction. , 2011, International journal of molecular medicine.
[31] E. Ghigo,et al. The Intensity of IUGR-Induced Transcriptome Deregulations Is Inversely Correlated with the Onset of Organ Function in a Rat Model , 2011, PloS one.
[32] Carmen J. Marsit,et al. miR-16 and miR-21 Expression in the Placenta Is Associated with Fetal Growth , 2011, PloS one.
[33] I. Brosens,et al. Defective deep placentation. , 2011, Best practice & research. Clinical obstetrics & gynaecology.
[34] J. Dumoulin,et al. Epigenetics and the placenta. , 2011, Human reproduction update.
[35] A. Odibo,et al. Diagnosis and Management of Fetal Growth Restriction , 2011, Journal of pregnancy.
[36] A. Gruslin,et al. Sildenafil citrate therapy for severe early‐onset intrauterine growth restriction , 2011, BJOG : an international journal of obstetrics and gynaecology.
[37] T. Todros,et al. Review: Feto-placental vascularization: a multifaceted approach. , 2011, Placenta.
[38] B. Manning,et al. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis , 2011, Trends in Endocrinology & Metabolism.
[39] R. Romero,et al. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. , 2011, American journal of obstetrics and gynecology.
[40] D. Spandidos,et al. Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. , 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[41] T. Hata,et al. Three-dimensional ultrasound evaluation of the placenta. , 2011, Placenta.
[42] Y. Kanai,et al. Maternal Protein Restriction in the Rat Inhibits Placental Insulin, mTOR, and STAT3 Signaling and Down-Regulates Placental Amino Acid Transporters , 2011, Endocrinology.
[43] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[44] A. Smerieri,et al. Impairment of insulin receptor signal transduction in placentas of intra-uterine growth-restricted newborns and its relationship with fetal growth. , 2011, European journal of endocrinology.
[45] I. Crocker,et al. Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast , 2011, Apoptosis.
[46] I. Crocker,et al. Placental Apoptosis in Health and Disease , 2010, American journal of reproductive immunology.
[47] S. Brennecke,et al. Placental biglycan expression is decreased in human idiopathic fetal growth restriction. , 2010, Placenta.
[48] R. Chapin,et al. Maternal-placental insulin-like growth factor (IGF) signaling and its importance to normal embryo-fetal development. , 2010, Birth defects research. Part B, Developmental and reproductive toxicology.
[49] S. Brennecke,et al. Decorin expression is decreased in human idiopathic fetal growth restriction. , 2010, Reproduction, fertility, and development.
[50] Nicholas T. Ingolia,et al. Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.
[51] I. Cetin,et al. Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction , 2010, Epigenetics.
[52] R. Yuen,et al. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia , 2010, European Journal of Human Genetics.
[53] Majida Abu Shehab,et al. Site-specific IGFBP-1 hyper-phosphorylation in fetal growth restriction: clinical and functional relevance. , 2010, Journal of proteome research.
[54] M. Tuuli,et al. First‐trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction , 2010, Prenatal diagnosis.
[55] G. Rice,et al. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. , 2010, Placenta.
[56] R. Schild,et al. Microarray analysis of placental tissue in intrauterine growth restriction , 2010, Clinical endocrinology.
[57] L. Moore. The Placenta and Human Developmental Programming: Uterine blood flow as a determinant of fetoplacental development , 2010 .
[58] D. Charnock-Jones,et al. The influence of the intrauterine environment on human placental development. , 2010, The International journal of developmental biology.
[59] T. Marton,et al. Pathological assessment of intrauterine growth restriction. , 2009, Best practice & research. Clinical obstetrics & gynaecology.
[60] P. Kyle,et al. Aetiology and pathogenesis of IUGR. , 2009, Best practice & research. Clinical obstetrics & gynaecology.
[61] R. Cruz‐Martínez,et al. The role of Doppler and placental screening. , 2009, Best practice & research. Clinical obstetrics & gynaecology.
[62] Majida Abu Shehab,et al. Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical relevancy in fetal growth restriction. , 2009, Journal of proteome research.
[63] T. Powell,et al. The role of trophoblast nutrient and ion transporters in the development of pregnancy complications and adult disease. , 2009, Current vascular pharmacology.
[64] C. Marsit,et al. REVIEW ARTICLE: Epigenetics in the Placenta , 2009, American journal of reproductive immunology.
[65] I. Crocker,et al. Utero-placental haemodynamics in the pathogenesis of pre-eclampsia. , 2009, Placenta.
[66] J. Aplin,et al. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. , 2009, The American journal of pathology.
[67] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[68] Y. Kanai,et al. Regulation of placental amino acid transporter activity by mammalian target of rapamycin. , 2009, American journal of physiology. Cell physiology.
[69] I. Crocker,et al. Live and let die - regulation of villous trophoblast apoptosis in normal and abnormal pregnancies. , 2008, Placenta.
[70] Wieland Kiess,et al. IGF signaling defects as causes of growth failure and IUGR , 2008, Trends in Endocrinology & Metabolism.
[71] D. Charnock-Jones,et al. Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. , 2008, The American journal of pathology.
[72] J. Morrison. SHEEP MODELS OF INTRAUTERINE GROWTH RESTRICTION: FETAL ADAPTATIONS AND CONSEQUENCES , 2008, Clinical and experimental pharmacology & physiology.
[73] D. Skupski,et al. Intrauterine restriction (IUGR) , 2008, Journal of perinatal medicine.
[74] R. Tyson,et al. The intrauterine growth-restricted fetus and placenta evaluation. , 2008, Seminars in perinatology.
[75] I. Bernstein,et al. Optimal growth modeling. , 2008, Seminars in perinatology.
[76] B. Manning,et al. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. , 2008, The Biochemical journal.
[77] R. Lane,et al. Programmed Upregulation of Adipogenic Transcription Factors in Intrauterine Growth-Restricted Offspring , 2008, Reproductive Sciences.
[78] Y. Sadovsky,et al. PPAR Signaling in Placental Development and Function , 2007, PPAR research.
[79] Jing Xu,et al. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. , 2008, The Journal of clinical endocrinology and metabolism.
[80] Luciano Marcondes Machado Nardozza,et al. Placenta: angiogenesis and vascular assessment through three-dimensional power Doppler ultrasonography , 2008, Archives of Gynecology and Obstetrics.
[81] Y. Sadovsky,et al. Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. , 2007, American journal of obstetrics and gynecology.
[82] T. Powell,et al. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down‐regulated in restricted fetal growth , 2007, The Journal of physiology.
[83] V. V. van Hinsbergh,et al. Different degrees of vascularization and their relationship to the expression of vascular endothelial growth factor, placental growth factor, angiopoietins, and their receptors in first-trimester decidual tissues. , 2007, Fertility and sterility.
[84] C. Ananth,et al. Risk factors for antepartum and intrapartum stillbirth: a population-based study. , 2007, American journal of obstetrics and gynecology.
[85] S. Elmore. Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.
[86] W. Reik. Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.
[87] I. Cetin,et al. Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition. , 2007, American journal of physiology. Endocrinology and metabolism.
[88] M. Beckmann,et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. , 2007, Clinical science.
[89] V. Ganapathy,et al. Down‐regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet , 2006, The Journal of physiology.
[90] C. Sibley,et al. Placental Lactate Transporter Activity and Expression in Intrauterine Growth Restriction , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.
[91] R. Weksberg,et al. Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. , 2006, Placenta.
[92] D. Maulik. Fetal growth compromise: definitions, standards, and classification. , 2006, Clinical obstetrics and gynecology.
[93] D. Maulik. Fetal growth restriction: the etiology. , 2006, Clinical obstetrics and gynecology.
[94] Y. Sadovsky,et al. The pleiotropic function of PPARγ in the placenta , 2006, Molecular and Cellular Endocrinology.
[95] S Apostolidou,et al. Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. , 2006, Human molecular genetics.
[96] M. Senat,et al. Customized versus population-based birth weight standards for identifying growth restricted infants: a French multicenter study. , 2006, American journal of obstetrics and gynecology.
[97] D. Tollefsen,et al. Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II. , 2006, Blood.
[98] A. Okamoto,et al. IGFBP1 and Follistatin-like 3 genes are significantly up-regulated in expression profiles of the IUGR placenta. , 2006, Placenta.
[99] J. Kingdom,et al. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. , 2006, American journal of obstetrics and gynecology.
[100] I. Cetin,et al. Placental LPL Gene Expression Is Increased in Severe Intrauterine Growth-Restricted Pregnancies , 2006, Pediatric Research.
[101] I. Sandovici,et al. Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[102] Michael Lehrke,et al. The Many Faces of PPARγ , 2005, Cell.
[103] Thomas Jansson,et al. Placental Phenotypes of Intrauterine Growth , 2005, Pediatric Research.
[104] John Calvin Reed,et al. Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.
[105] Pinchas Cohen,et al. The role of the insulin-like growth factor system in prenatal growth. , 2005, Molecular genetics and metabolism.
[106] A. Okamoto,et al. Frequent apoptosis in placental villi from pregnancies complicated with intrauterine growth restriction and without maternal symptoms. , 2005, International journal of molecular medicine.
[107] G. Burton,et al. Placental morphometry and Doppler flow velocimetry in cases of chronic human fetal hypoxia. , 2005, European journal of obstetrics, gynecology, and reproductive biology.
[108] A. Ferguson-Smith,et al. Imprinted genes in the placenta--a review. , 2005, Placenta.
[109] Y. Sadovsky,et al. Microarray-based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. , 2005, Placenta.
[110] R. Giorgino,et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. , 2005, Endocrinology.
[111] V. Han,et al. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs. , 2005, The Journal of endocrinology.
[112] T. Mayhew,et al. Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. , 2004, Placenta.
[113] B. Stray-Pedersen,et al. Restricted fetal growth in sudden intrauterine unexplained death , 2004, Acta obstetricia et gynecologica Scandinavica.
[114] E. Jauniaux,et al. Placental Oxidative Stress: From Miscarriage to Preeclampsia , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.
[115] T. Powell,et al. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. , 2004, The Journal of clinical endocrinology and metabolism.
[116] N. Sonenberg,et al. Upstream and downstream of mTOR. , 2004, Genes & development.
[117] A. Correa,et al. A review of the literature on the effects of ambient air pollution on fetal growth. , 2004, Environmental research.
[118] A. Romo,et al. Study of genetic expression of intrauterine growth factors IGF-I and EGFR in placental tissue from pregnancies with intrauterine growth retardation. , 2004, Journal of pediatric endocrinology & metabolism : JPEM.
[119] R. Bahado-Singh,et al. Fetal Doppler velocimetry. , 2004, Obstetrics and gynecology clinics of North America.
[120] E. Ferrazzi,et al. Differences in fat and lean mass proportions in normal and growth-restricted fetuses. , 2003, American journal of obstetrics and gynecology.
[121] H. Schröder. Models of fetal growth restriction. , 2003, European journal of obstetrics, gynecology, and reproductive biology.
[122] J. Howell,et al. A Novel Hypoxia-inducible Factor-independent Hypoxic Response Regulating Mammalian Target of Rapamycin and Its Targets* , 2003, Journal of Biological Chemistry.
[123] R. Wilkening,et al. The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction , 2003, The Journal of physiology.
[124] B. Brenner,et al. Haemostatic mechanisms in human placenta. , 2003, Best practice & research. Clinical haematology.
[125] T. Powell,et al. Activity and protein expression of Na+/K+ ATPase are reduced in microvillous syncytiotrophoblast plasma membranes isolated from pregnancies complicated by intrauterine growth restriction. , 2003, The Journal of clinical endocrinology and metabolism.
[126] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .
[127] B. Johansson,et al. Leptin stimulates the activity of the system A amino acid transporter in human placental villous fragments. , 2003, The Journal of clinical endocrinology and metabolism.
[128] P. Baker,et al. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. , 2003, Placenta.
[129] J. Kingdom,et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. , 2003, Placenta.
[130] Michael N. Hall,et al. TOR signalling in bugs, brain and brawn , 2003, Nature Reviews Molecular Cell Biology.
[131] H. Athapathu,et al. A study of the incidence of apoptosis in the human placental cells in the last weeks of pregnancy , 2003, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[132] E. Jauniaux,et al. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. , 2003, The American journal of pathology.
[133] C. Sibley,et al. Activity and protein expression of the Na+/H+ exchanger is reduced in syncytiotrophoblast microvillous plasma membranes isolated from preterm intrauterine growth restriction pregnancies. , 2002, The Journal of clinical endocrinology and metabolism.
[134] T. Powell,et al. Parathyroid hormone-related peptide (38-94) amide stimulates ATP-dependent calcium transport in the Basal plasma membrane of the human syncytiotrophoblast. , 2002, The Journal of endocrinology.
[135] B. Tycko,et al. Physiological functions of imprinted genes , 2002, Journal of cellular physiology.
[136] Chie-Pein Chen,et al. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. , 2002, American journal of obstetrics and gynecology.
[137] C. C. Pillai,et al. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. , 2002, The Journal of clinical investigation.
[138] R. Simmons,et al. Placental Expression of Insulin-Like Growth Factor Receptor-1 and Insulin Receptor in the Growth-Restricted Fetal Rat , 2002, The Journal of the Society for Gynecologic Investigation: JSGI.
[139] D. Charnock-Jones,et al. Hypoxia-Reoxygenation: A Potent Inducer of Apoptotic Changes in the Human Placenta and Possible Etiological Factor in Preeclampsia , 2002, Circulation research.
[140] W. Reik,et al. Placental-specific IGF-II is a major modulator of placental and fetal growth , 2002, Nature.
[141] Y. Sadovsky,et al. Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. , 2002, American journal of obstetrics and gynecology.
[142] T. Powell,et al. Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction. , 2002, Placenta.
[143] C. Sibley,et al. Pathogenesis of intrauterine growth restriction (IUGR)-conclusions derived from a European Union Biomed 2 Concerted Action project 'Importance of Oxygen Supply in Intrauterine Growth Restricted Pregnancies'-a workshop report. , 2002, Placenta.
[144] K. Maršál,et al. Can the degree of retrograde diastolic flow in abnormal umbilical artery flow velocity waveforms predict pregnancy outcome? , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[145] R. Wilkening,et al. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR). , 2002, Placenta.
[146] A. Jaeschke,et al. Mammalian TOR: A Homeostatic ATP Sensor , 2001, Science.
[147] G. Pardi,et al. Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. , 2001, The Journal of clinical endocrinology and metabolism.
[148] K. Marsh,et al. Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae , 2001, Tropical medicine & international health : TM & IH.
[149] C. Proud,et al. Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.
[150] Z. Calay,et al. Apoptosis in the placenta of pregnancies complicated with IUGR , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[151] F. Petraglia,et al. Human Placenta as a Source of Neuroendocrine Factors , 2001, Neonatology.
[152] C. Dalçik,et al. Expression of insulin-like growth factor in the placenta of intrauterine growth-retarded human fetuses. , 2001, Acta histochemica.
[153] N. Kanayama,et al. Intraplacental Coagulation in Intrauterine Growth Restriction: Cause or Result? , 2001, Seminars in thrombosis and hemostasis.
[154] W. Reik,et al. Genomic imprinting: parental influence on the genome , 2001, Nature Reviews Genetics.
[155] L. Vatten,et al. Preeclampsia and Fetal Growth , 2000, Obstetrics and gynecology.
[156] W. Ott. Intrauterine growth restriction and Doppler ultrasonography. , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[157] B Huppertz,et al. Development of the placental villous tree and its consequences for fetal growth. , 2000, European journal of obstetrics, gynecology, and reproductive biology.
[158] E. Gilbert-Barness,et al. Abnormal Umbilical Cord Coiling Is Associated with Adverse Perinatal Outcomes , 2000, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[159] R. Jaffe,et al. Role of angiopoietins in reproductive tract angiogenesis. , 2000, Obstetrical & gynecological survey.
[160] B. Bussolati,et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. , 2000, The American journal of pathology.
[161] S. O’Rahilly,et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension , 1999, Nature.
[162] K. Nicolaides,et al. The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by doppler ultrasound. , 1999, Human reproduction.
[163] N. Özdemir,et al. The Comparison of Uterine Artery Doppler Velocimetry with the Histopathology of the Placental Bed , 1999, The Australian & New Zealand journal of obstetrics & gynaecology.
[164] J. Kingdom,et al. Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. , 1999, Obstetrics and gynecology.
[165] A. N. Corps,et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. , 1998, Biology of reproduction.
[166] R. Ohlsson,et al. The H19 Transcript Is Associated with Polysomes and May Regulate IGF2 Expression intrans* , 1998, The Journal of Biological Chemistry.
[167] T. Powell,et al. Placental Transport of Leucine and Lysine Is Reduced in Intrauterine Growth Restriction1 , 1998, Pediatric Research.
[168] T. Powell,et al. Intrauterine Growth Restriction Is Associated with a Reduced Activity of Placental Taurine Transporters , 1998, Pediatric Research.
[169] M. Andrew,et al. Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta. , 1998, Thrombosis research.
[170] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[171] M. Iwashita,et al. Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells. , 1998 .
[172] P. Baker,et al. Increased placental apoptosis in intrauterine growth restriction. , 1997, American journal of obstetrics and gynecology.
[173] J. Harding,et al. Antenatal therapy for intrauterine growth retardation , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[174] C. Sibley,et al. Association between the Activity of the System A Amino Acid Transporter in the Microvillous Plasma Membrane of the Human Placenta and Severity of Fetal Compromise in Intrauterine Growth Restriction , 1997, Pediatric Research.
[175] J. Kingdom,et al. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. , 1997, Placenta.
[176] C. Taylor,et al. Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines: JEG, JAr and BeWo. , 1997, Placenta.
[177] J. Kingdom,et al. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. , 1996, American journal of obstetrics and gynecology.
[178] G. Greisen,et al. Growth hormone, insulin‐like growth factor I and its binding proteins 1 and 3 in last trimester intrauterine growth retardation with increased pulsatility index in the umbilical artery , 1996, Clinical endocrinology.
[179] J. Kingdom,et al. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. , 1996, Placenta.
[180] M. Whittle,et al. Localisation of placenta growth factor (PIGF) in human term placenta. , 1996, Growth factors.
[181] P. Karl. Insulin‐like growth factor‐1 stimulates amino acid uptake by the cultured human placental trophoblast , 1995, Journal of cellular physiology.
[182] J. Newnham,et al. Screening for the Small Fetus: A Study of the Relative Efficacies of Ultrasound Biometry and Symphysiofundal Height , 1995, The Australian & New Zealand journal of obstetrics & gynaecology.
[183] X. Shu,et al. Maternal Smoking, Alcohol Drinking, Caffeine Consumption, and Fetal Growth: Results from a Prospective Study , 1995, Epidemiology.
[184] S. Gabbe,et al. Insulinlike growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. , 1994, The Journal of reproductive medicine.
[185] T. Jansson,et al. Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. , 1993, The Journal of clinical endocrinology and metabolism.
[186] C. Sibley,et al. Amino Acid (System A) Transporter Activity in Microvillous Membrane Vesicles from the Placentas of Appropriate and Small for Gestational Age Babies , 1993, Pediatric Research.
[187] J. Baker,et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.
[188] Elizabeth J. Robertson,et al. Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.
[189] A. Carter. Current topic: restriction of placental and fetal growth in the guinea-pig. , 1993, Placenta.
[190] R. Boys,et al. Prediction Of The Small For Gestational Age Infant: Which Ultrasonic Measurement Is Best? , 1992, Obstetrics and gynecology.
[191] K. Copeland,et al. Secretion of prolactin and insulin-like growth factor I by decidual explant cultures from pregnancies complicated by intrauterine growth retardation. , 1992 .
[192] G. Visser,et al. The effects of maternal hyperoxia on fetal breathing movements, body movements and heart rate variation in growth retarded fetuses. , 1991, Early human development.
[193] J. Kopelman,et al. The Association of Antiphospholipid Antibodies With Pregnancies Complicated by Fetal Growth Restriction , 1991, Obstetrics and gynecology.
[194] A. Avilés,et al. Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children , 1991, American journal of hematology.
[195] K. Maršál,et al. Blood Velocity Waveforms in the Fetal Aorta and Umbilical Artery as Predictors of Fetal Outcome: A Comparison , 1991, American journal of perinatology.
[196] T. Jansson,et al. Placental Transfer of Glucose and Amino Acids in Intrauterine Growth Retardation: Studies with Substrate Analogs in the Awake Guinea Pig , 1990, Pediatric Research.
[197] F. Cunningham,et al. Chronic renal disease and pregnancy outcome , 1990, American journal of obstetrics and gynecology.
[198] A. Efstratiadis,et al. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting , 1990, Nature.
[199] E. Mammen,et al. Increased Intravascular Coagulation Associated With Pregnancy , 1990, Obstetrics and gynecology.
[200] G. Pardi,et al. Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis. , 1990, American journal of obstetrics and gynecology.
[201] K. Nicolaides,et al. Plasma amino acids in appropriate- and small-for-gestational-age fetuses. , 1989 .
[202] M. Khoury,et al. Congenital malformations and intrauterine growth retardation: a population study. , 1988, Pediatrics.
[203] K Marsál,et al. Umbilical Artery and Uteroplacental Blood Flow Velocity Waveforms in Normal Pregnancy — A Cross‐Sectional Study , 1988, Acta obstetricia et gynecologica Scandinavica.
[204] G. Kissling,et al. Ultrasonic Recognition of the Small‐for‐Gestational‐Age Fetus , 1987, Obstetrics and gynecology.
[205] S. Campbell,et al. Routine Ultrasound Screening for Antenatal Detection of Intrauterine Growth Retardation , 1986, Obstetrics and gynecology.
[206] A. Scott,et al. Risk factors associated with small‐for‐dates and large‐for‐dates infants , 1985 .
[207] H. Wilken,et al. [Intraamniotic amino acid infusions in chronic placental insufficiency]. , 1977, Zentralblatt fur Gynakologie.
[208] Wigglesworth Js. Fetal growth retardation. Animal model: uterine vessel ligation in the pregnant rat. , 1974 .
[209] R. Naeye,et al. Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress. , 1973, The Journal of pediatrics.